Aspire Biopharma completes $30 million acquisition of Dura Driver Control Systems
ASBP•Dura Driver Control Systems financials and management
Dura Driver Control Systems reported $209.5 million revenue and $22.3 million adjusted EBITDA for 2025.
For the six months ended June 30, 2026, DCS generated about $103.9 million revenue and $10.5 million adjusted EBITDA.
DCS CEO Hans Vorstenbosch remains in charge of the unit, with the existing management team.
Aspire Biopharma completes Dura Driver Control Systems acquisition
Aspire Biopharma completed its acquisition of Dura Driver Control Systems, buying 100% of the shares for about $30 million cash.
Funding included a new $22.5 million senior secured revolving credit facility, supplemented by cash on hand.
